Plasma-derived versus recombinant Factor VIII concentrates for the treatment of haemophilia A: recombinant is better

類似資料

• Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better
  著者:: Mannucci, Pier Mannuccio
  出版事項: (2010)
• Factor VIII safety: plasma-derived versus recombinant products
  著者:: Gringeri, Alessandro
  出版事項: (2011)
• Recombinant factor VIII Fc for the treatment of haemophilia A
  著者:: Hermans, Cedric, 等
  出版事項: (2021)
• Recombinant factor VIIa concentrate versus plasma‐derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors
  著者:: Matino, Davide, 等
  出版事項: (2015)
• Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX
  著者:: Rocino, Angiola, 等
  出版事項: (2017)